ID
12846
Description
Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00471549
Link
https://clinicaltrials.gov/show/NCT00471549
Keywords
Versions (1)
- 12/29/15 12/29/15 -
Uploaded on
December 29, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes NCT00471549
Eligibility Type 2 Diabetes NCT00471549
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
signs of primary kidney disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0022658
Description
signs of primary hepatic disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0023895
Description
signs of insufficiently treated cardiac disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
Similar models
Eligibility Type 2 Diabetes NCT00471549
- StudyEvent: Eligibility